Related Experiment Video

Updated: Oct 13, 2026

Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

[Fibrinolytic treatment in acute myocardial infarction: analysis of delay]

M L Iglesias1, J Pedro-Botet, E Hernández

  • 1Servicios de Urgencias, Universidad Autónoma de Barcelona.

Medicina Clinica
|March 2, 1996
PubMed

Insights

Delays in initiating fibrinolytic treatment for acute myocardial infarction (AMI) are significant, particularly intrahospital delays. Decision-making processes contribute most to the time lag, impacting patient outcomes.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Clinical Research

Background:

  • Acute myocardial infarction (AMI) requires timely intervention.
  • Intravenous fibrinolytic therapy is a critical treatment for AMI.
  • Understanding treatment delays is crucial for improving patient care.

Purpose of the Study:

  • To analyze the delay times in initiating intravenous fibrinolytic treatment for AMI patients.
  • To identify specific components contributing to total treatment delay.
  • To evaluate factors influencing intrahospital delay in fibrinolysis administration.

Main Methods:

  • A retrospective study of consecutive AMI patients treated at Hospital del Mar, Barcelona.
  • Inclusion criteria: transmural AMI, age < 80 years, symptom onset < 6 hours.
  • Analysis of total, extrahospitalary, and intrahospitalary delay times, including assistance, indication, and performance delays.

Main Results:

  • Of 80 AMI patients, 33 received fibrinolytic treatment.
  • Total delay time averaged 287.2 minutes.
  • Intrahospitalary delay was 126.8 minutes, largely due to a 78.8-minute delay in treatment indication.

Conclusions:

  • Decision delays significantly contribute to intrahospitalary delays in fibrinolytic treatment administration for AMI.
  • Optimizing the decision-making process is key to reducing treatment times.
  • Further research into streamlining treatment protocols is warranted.
Abstract

More Related Videos

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures10:01

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures

Published on: March 12, 2018

Related Concept Videos

Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...